A MUTATIONAL ANALYSIS OF RECEPTOR-BINDING SITES OF INTERLEUKIN-1-BETA - DIFFERENCES IN BINDING OF HUMAN INTERLEUKIN-1-BETA MUTEINS TO HUMAN AND MOUSE RECEPTORS
被引:31
|
作者:
GRUTTER, MG
论文数: 0引用数: 0
h-index: 0
机构:
CIBA GEIGY AG, DEPT INFLAMMAT BONE & ALLERGY, DIV PHARMACEUT, CH-4002 BASEL, SWITZERLANDCIBA GEIGY AG, DEPT INFLAMMAT BONE & ALLERGY, DIV PHARMACEUT, CH-4002 BASEL, SWITZERLAND
GRUTTER, MG
[1
]
VANOOSTRUM, J
论文数: 0引用数: 0
h-index: 0
机构:
CIBA GEIGY AG, DEPT INFLAMMAT BONE & ALLERGY, DIV PHARMACEUT, CH-4002 BASEL, SWITZERLANDCIBA GEIGY AG, DEPT INFLAMMAT BONE & ALLERGY, DIV PHARMACEUT, CH-4002 BASEL, SWITZERLAND
VANOOSTRUM, J
[1
]
PRIESTLE, JP
论文数: 0引用数: 0
h-index: 0
机构:
CIBA GEIGY AG, DEPT INFLAMMAT BONE & ALLERGY, DIV PHARMACEUT, CH-4002 BASEL, SWITZERLANDCIBA GEIGY AG, DEPT INFLAMMAT BONE & ALLERGY, DIV PHARMACEUT, CH-4002 BASEL, SWITZERLAND
PRIESTLE, JP
[1
]
EDELMANN, E
论文数: 0引用数: 0
h-index: 0
机构:
CIBA GEIGY AG, DEPT INFLAMMAT BONE & ALLERGY, DIV PHARMACEUT, CH-4002 BASEL, SWITZERLANDCIBA GEIGY AG, DEPT INFLAMMAT BONE & ALLERGY, DIV PHARMACEUT, CH-4002 BASEL, SWITZERLAND
EDELMANN, E
[1
]
JOSS, U
论文数: 0引用数: 0
h-index: 0
机构:
CIBA GEIGY AG, DEPT INFLAMMAT BONE & ALLERGY, DIV PHARMACEUT, CH-4002 BASEL, SWITZERLANDCIBA GEIGY AG, DEPT INFLAMMAT BONE & ALLERGY, DIV PHARMACEUT, CH-4002 BASEL, SWITZERLAND
JOSS, U
[1
]
FEIGE, U
论文数: 0引用数: 0
h-index: 0
机构:
CIBA GEIGY AG, DEPT INFLAMMAT BONE & ALLERGY, DIV PHARMACEUT, CH-4002 BASEL, SWITZERLANDCIBA GEIGY AG, DEPT INFLAMMAT BONE & ALLERGY, DIV PHARMACEUT, CH-4002 BASEL, SWITZERLAND
FEIGE, U
[1
]
VOSBECK, K
论文数: 0引用数: 0
h-index: 0
机构:
CIBA GEIGY AG, DEPT INFLAMMAT BONE & ALLERGY, DIV PHARMACEUT, CH-4002 BASEL, SWITZERLANDCIBA GEIGY AG, DEPT INFLAMMAT BONE & ALLERGY, DIV PHARMACEUT, CH-4002 BASEL, SWITZERLAND
VOSBECK, K
[1
]
SCHMITZ, A
论文数: 0引用数: 0
h-index: 0
机构:
CIBA GEIGY AG, DEPT INFLAMMAT BONE & ALLERGY, DIV PHARMACEUT, CH-4002 BASEL, SWITZERLANDCIBA GEIGY AG, DEPT INFLAMMAT BONE & ALLERGY, DIV PHARMACEUT, CH-4002 BASEL, SWITZERLAND
SCHMITZ, A
[1
]
机构:
[1] CIBA GEIGY AG, DEPT INFLAMMAT BONE & ALLERGY, DIV PHARMACEUT, CH-4002 BASEL, SWITZERLAND
INTERLEUKIN-1-BETA;
MUTATIONAL MAPPING;
RECEPTOR BINDING;
SPECIES DIFFERENCE;
D O I:
10.1093/protein/7.5.663
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
The 3-D crystal structure of interleukin-1 beta (IL-1 beta) has been used to define its receptor binding surface by mutational analysis. The surface of IL-1 beta was probed by site-directed mutagenesis. A total of 27 different IL-1 beta muteins were constructed, purified and analyzed. Receptor binding measurements on mouse and human cell lines were performed to identify receptor affinities. IL-1 beta muteins with modified receptor affinity were evaluated for structural integrity by CD spectroscopy or X-ray crystallography. Changes in six surface loops, as well as in the C- and N-termini, yielded muteins with lower binding affinities. Two muteins with intact binding affinities showed 10- to 100-fold reduced biological activity. The surface region involved in receptor binding constitutes a discontinuous area of similar to 1000 Angstrom(2) formed by discontinuous polypeptide chain stretches. Based on these results, a subdivision into two distinct local areas is proposed. Differences in receptor binding affinities for human and mouse receptors have been observed for some muteins, but not for wild-type IL-1 beta. This is the first time a difference in binding affinity of IL-1 beta muteins to human and mouse receptors has been demonstrated.